<--- Back to Details
First PageDocument Content
Health / Thalassemia / Beta-thalassemia / HBA2 / Hemoglobin E / Hemoglobin / HBD / HBB / Hereditary persistence of fetal hemoglobin / Hemoglobins / Medicine / Biology
Date: 2007-03-07 08:10:19
Health
Thalassemia
Beta-thalassemia
HBA2
Hemoglobin E
Hemoglobin
HBD
HBB
Hereditary persistence of fetal hemoglobin
Hemoglobins
Medicine
Biology

The Cypriot and Iranian National Mutation Frequency databases

Add to Reading List

Source URL: globin.bx.psu.edu

Download Document from Source Website

File Size: 362,18 KB

Share Document on Facebook

Similar Documents

Marina Cavazzana [Mode de compatibilité]

Marina Cavazzana [Mode de compatibilité]

DocID: 1p4cO - View Document

I would like to donate Name ............................................................................................... Diagnostic Lab Thalassemia & Sickle Cell Society Vuppala Krishna Rao & Chandrakala Diagnostic

I would like to donate Name ............................................................................................... Diagnostic Lab Thalassemia & Sickle Cell Society Vuppala Krishna Rao & Chandrakala Diagnostic

DocID: 1oVFa - View Document

Sickle Cell Awareness  Sickle Cell Disease (SCD) is an assembly of inherited red blood cell disorders. People with SCD have abnormal hemoglobin, termed as hemoglobin S or sickle hemoglobin, in their red blood cells. Inhe

Sickle Cell Awareness Sickle Cell Disease (SCD) is an assembly of inherited red blood cell disorders. People with SCD have abnormal hemoglobin, termed as hemoglobin S or sickle hemoglobin, in their red blood cells. Inhe

DocID: 1onjc - View Document

Beta Thalassemia Genetic Testing Interpretation Order Form Patient´s name (first name, last name)

DocID: 1crRW - View Document

CORPORATE FACT SHEET December 2013 Acceleron is a biopharmaceutical company committed to discover, develop, manufacture and commercialize novel protein therapeutics for cancer and orphan diseases Acceleron’s scientific

CORPORATE FACT SHEET December 2013 Acceleron is a biopharmaceutical company committed to discover, develop, manufacture and commercialize novel protein therapeutics for cancer and orphan diseases Acceleron’s scientific

DocID: 19vEv - View Document